NeuroSense Therapeutics (NRSN) Research & Development (2021 - 2024)
NeuroSense Therapeutics' (NRSN) quarterly Research & Development came in at -$1.1 million in Q4 2024, up 43.02% year-over-year from -$759323.6 in Q1 2024, and up 86.99% quarter-over-quarter from -$8.3 million in Q3 2024.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Research & Development (2021 - 2024) Analysis & Trends
NeuroSense Therapeutics has disclosed Research & Development across 4 years of filings, most recently posting -$1.1 million for Q4 2024.
- In Q4 2024, Research & Development rose 43.02% year-over-year to -$1.1 million; the TTM figure through Dec 2024 stood at -$5.7 million (up 21.67% YoY), while the FY2025 annual figure was -$6.2 million, down 9.28% from the prior year.
- Research & Development came in at -$1.1 million for Q4 2024 at NeuroSense Therapeutics, up from -$8.3 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $5.6 million in Q2 2024 to a low of -$8.3 million in Q3 2024.
- Average Research & Development over 4 years is -$1.1 million, with a median of -$1.6 million recorded in 2023.
- The largest YoY upside for Research & Development was 386.77% in 2024 against a maximum downside of 435.62% in 2024.
- Over 4 years, Research & Development stood at $4.4 million in 2021, then slumped by 116.14% to -$715000.0 in 2022, then sank by 166.57% to -$1.9 million in 2023, then jumped by 43.02% to -$1.1 million in 2024.
- Per Business Quant data, the three most recent Research & Development figures were -$1.1 million in Q4 2024, -$8.3 million in Q3 2024, and $5.6 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 1.87 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 1.76 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 993.80 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 1.63 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 651.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | -486.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 413.13 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 529.60 Mn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 202.02 Mn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1.09 Mn |
| Sep 30, 2024 | -8.35 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | -1.88 Mn |
| Dec 31, 2023 | -1.91 Mn |
| Sep 30, 2023 | -1.56 Mn |
| Jun 30, 2023 | -1.96 Mn |
| Mar 31, 2023 | -1.85 Mn |
| Dec 31, 2022 | -715,000.00 |
| Sep 30, 2022 | -8.04 Mn |
| Jun 30, 2022 | 4.46 Mn |
| Mar 31, 2022 | -1.30 Mn |
| Dec 31, 2021 | 4.43 Mn |
API Access
NeuroSense Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();